| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8475150 | Journal of Molecular and Cellular Cardiology | 2013 | 6 Pages |
Abstract
⺠NHE-1 inhibitors protect the ischemic and reperfused myocadium. ⺠Clinical trials have produced diverse results as well as evidence of adverse effects. ⺠The bases for clinical results can likely be rationalized based on various factors. ⺠NHE-1 inhibitors reduce heart failure and improve post-cardiac arrest resuscitation. ⺠Further development of NHE-1 inhibitors for cardiac therapeutics is warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Morris Karmazyn,